nodes	percent_of_prediction	percent_of_DWPC	metapath
Desloratadine—CYP2D6—Hydroxyurea—head and neck cancer	0.28	0.342	CbGbCtD
Desloratadine—CYP1A2—Fluorouracil—head and neck cancer	0.13	0.159	CbGbCtD
Desloratadine—CYP2C9—Fluorouracil—head and neck cancer	0.117	0.143	CbGbCtD
Desloratadine—ABCB1—Vinblastine—head and neck cancer	0.105	0.129	CbGbCtD
Desloratadine—CYP2D6—Vinblastine—head and neck cancer	0.0992	0.121	CbGbCtD
Desloratadine—ABCB1—Docetaxel—head and neck cancer	0.0868	0.106	CbGbCtD
Desloratadine—Hepatic enzyme increased—Hydroxyurea—head and neck cancer	0.00454	0.0298	CcSEcCtD
Desloratadine—Rash maculo-papular—Hydroxyurea—head and neck cancer	0.0039	0.0256	CcSEcCtD
Desloratadine—Otitis media—Docetaxel—head and neck cancer	0.00286	0.0188	CcSEcCtD
Desloratadine—Breast disorder—Hydroxyurea—head and neck cancer	0.00282	0.0185	CcSEcCtD
Desloratadine—Rash maculo-papular—Fluorouracil—head and neck cancer	0.00281	0.0185	CcSEcCtD
Desloratadine—Rhinorrhoea—Docetaxel—head and neck cancer	0.00275	0.0181	CcSEcCtD
Desloratadine—Infestation NOS—Hydroxyurea—head and neck cancer	0.0024	0.0158	CcSEcCtD
Desloratadine—Infestation—Hydroxyurea—head and neck cancer	0.0024	0.0158	CcSEcCtD
Desloratadine—Blood bilirubin increased—Docetaxel—head and neck cancer	0.00236	0.0155	CcSEcCtD
Desloratadine—Pharyngitis—Vinblastine—head and neck cancer	0.00235	0.0154	CcSEcCtD
Desloratadine—Hepatobiliary disease—Hydroxyurea—head and neck cancer	0.00227	0.0149	CcSEcCtD
Desloratadine—Hallucination—Hydroxyurea—head and neck cancer	0.00214	0.0141	CcSEcCtD
Desloratadine—Irritability—Fluorouracil—head and neck cancer	0.00214	0.0141	CcSEcCtD
Desloratadine—Nasopharyngitis—Fluorouracil—head and neck cancer	0.00201	0.0132	CcSEcCtD
Desloratadine—Erythema—Hydroxyurea—head and neck cancer	0.00188	0.0123	CcSEcCtD
Desloratadine—CYP1A2—Arylamine metabolism—NAT2—head and neck cancer	0.00187	0.0648	CbGpPWpGaD
Desloratadine—Upper respiratory tract infection—Fluorouracil—head and neck cancer	0.0018	0.0118	CcSEcCtD
Desloratadine—Convulsion—Vinblastine—head and neck cancer	0.00178	0.0117	CcSEcCtD
Desloratadine—Infestation NOS—Fluorouracil—head and neck cancer	0.00173	0.0114	CcSEcCtD
Desloratadine—Infestation—Fluorouracil—head and neck cancer	0.00173	0.0114	CcSEcCtD
Desloratadine—Urinary tract infection—Fluorouracil—head and neck cancer	0.00168	0.011	CcSEcCtD
Desloratadine—Epistaxis—Fluorouracil—head and neck cancer	0.00163	0.0107	CcSEcCtD
Desloratadine—Convulsion—Hydroxyurea—head and neck cancer	0.00163	0.0107	CcSEcCtD
Desloratadine—Anorexia—Vinblastine—head and neck cancer	0.0016	0.0105	CcSEcCtD
Desloratadine—Pharyngitis—Fluorouracil—head and neck cancer	0.00154	0.0101	CcSEcCtD
Desloratadine—Oedema—Hydroxyurea—head and neck cancer	0.00153	0.0101	CcSEcCtD
Desloratadine—Infection—Hydroxyurea—head and neck cancer	0.00152	0.01	CcSEcCtD
Desloratadine—Nervous system disorder—Hydroxyurea—head and neck cancer	0.0015	0.00987	CcSEcCtD
Desloratadine—Breast disorder—Docetaxel—head and neck cancer	0.00146	0.00962	CcSEcCtD
Desloratadine—Anorexia—Hydroxyurea—head and neck cancer	0.00146	0.0096	CcSEcCtD
Desloratadine—Decreased appetite—Vinblastine—head and neck cancer	0.00146	0.0096	CcSEcCtD
Desloratadine—Nasopharyngitis—Docetaxel—head and neck cancer	0.00145	0.00952	CcSEcCtD
Desloratadine—Gastrointestinal pain—Vinblastine—head and neck cancer	0.00137	0.00903	CcSEcCtD
Desloratadine—Dyspnoea—Hydroxyurea—head and neck cancer	0.00137	0.00897	CcSEcCtD
Desloratadine—Somnolence—Hydroxyurea—head and neck cancer	0.00136	0.00895	CcSEcCtD
Desloratadine—Erythema—Fluorouracil—head and neck cancer	0.00135	0.00888	CcSEcCtD
Desloratadine—Dyspepsia—Hydroxyurea—head and neck cancer	0.00135	0.00886	CcSEcCtD
Desloratadine—Decreased appetite—Hydroxyurea—head and neck cancer	0.00133	0.00875	CcSEcCtD
Desloratadine—Abdominal pain—Vinblastine—head and neck cancer	0.00133	0.00873	CcSEcCtD
Desloratadine—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.00132	0.00869	CcSEcCtD
Desloratadine—Fatigue—Hydroxyurea—head and neck cancer	0.00132	0.00868	CcSEcCtD
Desloratadine—Infestation NOS—Docetaxel—head and neck cancer	0.00125	0.0082	CcSEcCtD
Desloratadine—Infestation—Docetaxel—head and neck cancer	0.00125	0.0082	CcSEcCtD
Desloratadine—Hypersensitivity—Vinblastine—head and neck cancer	0.00124	0.00813	CcSEcCtD
Desloratadine—Body temperature increased—Hydroxyurea—head and neck cancer	0.00121	0.00796	CcSEcCtD
Desloratadine—Asthenia—Vinblastine—head and neck cancer	0.0012	0.00792	CcSEcCtD
Desloratadine—Hepatobiliary disease—Docetaxel—head and neck cancer	0.00118	0.00776	CcSEcCtD
Desloratadine—Epistaxis—Docetaxel—head and neck cancer	0.00118	0.00773	CcSEcCtD
Desloratadine—Convulsion—Fluorouracil—head and neck cancer	0.00117	0.00769	CcSEcCtD
Desloratadine—Myalgia—Fluorouracil—head and neck cancer	0.00115	0.00756	CcSEcCtD
Desloratadine—Diarrhoea—Vinblastine—head and neck cancer	0.00115	0.00755	CcSEcCtD
Desloratadine—Hypersensitivity—Hydroxyurea—head and neck cancer	0.00113	0.00742	CcSEcCtD
Desloratadine—Hepatitis—Docetaxel—head and neck cancer	0.00112	0.00736	CcSEcCtD
Desloratadine—Pharyngitis—Docetaxel—head and neck cancer	0.00111	0.00731	CcSEcCtD
Desloratadine—Dizziness—Vinblastine—head and neck cancer	0.00111	0.0073	CcSEcCtD
Desloratadine—Anaphylactic shock—Fluorouracil—head and neck cancer	0.0011	0.00725	CcSEcCtD
Desloratadine—Oedema—Fluorouracil—head and neck cancer	0.0011	0.00725	CcSEcCtD
Desloratadine—Connective tissue disorder—Docetaxel—head and neck cancer	0.0011	0.00723	CcSEcCtD
Desloratadine—Asthenia—Hydroxyurea—head and neck cancer	0.0011	0.00722	CcSEcCtD
Desloratadine—Infection—Fluorouracil—head and neck cancer	0.0011	0.0072	CcSEcCtD
Desloratadine—Nervous system disorder—Fluorouracil—head and neck cancer	0.00108	0.00711	CcSEcCtD
Desloratadine—Tachycardia—Fluorouracil—head and neck cancer	0.00108	0.00707	CcSEcCtD
Desloratadine—Vomiting—Vinblastine—head and neck cancer	0.00107	0.00702	CcSEcCtD
Desloratadine—Headache—Vinblastine—head and neck cancer	0.00105	0.00692	CcSEcCtD
Desloratadine—Anorexia—Fluorouracil—head and neck cancer	0.00105	0.00691	CcSEcCtD
Desloratadine—Diarrhoea—Hydroxyurea—head and neck cancer	0.00105	0.00689	CcSEcCtD
Desloratadine—Cardiac disorder—Docetaxel—head and neck cancer	0.00104	0.00683	CcSEcCtD
Desloratadine—Dizziness—Hydroxyurea—head and neck cancer	0.00101	0.00666	CcSEcCtD
Desloratadine—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.001	0.0066	CcSEcCtD
Desloratadine—Nausea—Vinblastine—head and neck cancer	0.000997	0.00656	CcSEcCtD
Desloratadine—Insomnia—Fluorouracil—head and neck cancer	0.000997	0.00655	CcSEcCtD
Desloratadine—Dyspnoea—Fluorouracil—head and neck cancer	0.000983	0.00646	CcSEcCtD
Desloratadine—Mental disorder—Docetaxel—head and neck cancer	0.000981	0.00645	CcSEcCtD
Desloratadine—Somnolence—Fluorouracil—head and neck cancer	0.00098	0.00644	CcSEcCtD
Desloratadine—Erythema—Docetaxel—head and neck cancer	0.000975	0.00641	CcSEcCtD
Desloratadine—Vomiting—Hydroxyurea—head and neck cancer	0.000974	0.0064	CcSEcCtD
Desloratadine—Dyspepsia—Fluorouracil—head and neck cancer	0.00097	0.00638	CcSEcCtD
Desloratadine—Rash—Hydroxyurea—head and neck cancer	0.000966	0.00635	CcSEcCtD
Desloratadine—Dermatitis—Hydroxyurea—head and neck cancer	0.000965	0.00634	CcSEcCtD
Desloratadine—Headache—Hydroxyurea—head and neck cancer	0.000959	0.00631	CcSEcCtD
Desloratadine—Decreased appetite—Fluorouracil—head and neck cancer	0.000958	0.0063	CcSEcCtD
Desloratadine—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.000952	0.00626	CcSEcCtD
Desloratadine—Nausea—Hydroxyurea—head and neck cancer	0.00091	0.00598	CcSEcCtD
Desloratadine—CYP2C19—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A1—head and neck cancer	0.000893	0.0309	CbGpPWpGaD
Desloratadine—Urticaria—Fluorouracil—head and neck cancer	0.000876	0.00576	CcSEcCtD
Desloratadine—Body temperature increased—Fluorouracil—head and neck cancer	0.000871	0.00573	CcSEcCtD
Desloratadine—Palpitations—Docetaxel—head and neck cancer	0.000861	0.00566	CcSEcCtD
Desloratadine—Cough—Docetaxel—head and neck cancer	0.000851	0.00559	CcSEcCtD
Desloratadine—Convulsion—Docetaxel—head and neck cancer	0.000845	0.00555	CcSEcCtD
Desloratadine—Myalgia—Docetaxel—head and neck cancer	0.00083	0.00546	CcSEcCtD
Desloratadine—CYP1A2—Aflatoxin B1 metabolism—GSTM1—head and neck cancer	0.000817	0.0283	CbGpPWpGaD
Desloratadine—CYP2C9—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A1—head and neck cancer	0.000815	0.0282	CbGpPWpGaD
Desloratadine—CYP2C19—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A1—head and neck cancer	0.000813	0.0281	CbGpPWpGaD
Desloratadine—Hypersensitivity—Fluorouracil—head and neck cancer	0.000812	0.00534	CcSEcCtD
Desloratadine—Dry mouth—Docetaxel—head and neck cancer	0.000812	0.00534	CcSEcCtD
Desloratadine—Anaphylactic shock—Docetaxel—head and neck cancer	0.000796	0.00523	CcSEcCtD
Desloratadine—Oedema—Docetaxel—head and neck cancer	0.000796	0.00523	CcSEcCtD
Desloratadine—Infection—Docetaxel—head and neck cancer	0.00079	0.0052	CcSEcCtD
Desloratadine—Nervous system disorder—Docetaxel—head and neck cancer	0.00078	0.00513	CcSEcCtD
Desloratadine—Pruritus—Fluorouracil—head and neck cancer	0.00078	0.00513	CcSEcCtD
Desloratadine—Tachycardia—Docetaxel—head and neck cancer	0.000776	0.0051	CcSEcCtD
Desloratadine—Anorexia—Docetaxel—head and neck cancer	0.000758	0.00499	CcSEcCtD
Desloratadine—Diarrhoea—Fluorouracil—head and neck cancer	0.000754	0.00496	CcSEcCtD
Desloratadine—HRH1—IL-4 Signaling Pathway—CEBPA—head and neck cancer	0.000754	0.0261	CbGpPWpGaD
Desloratadine—CYP2C9—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A1—head and neck cancer	0.000741	0.0257	CbGpPWpGaD
Desloratadine—Dizziness—Fluorouracil—head and neck cancer	0.000729	0.00479	CcSEcCtD
Desloratadine—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.000725	0.00476	CcSEcCtD
Desloratadine—Insomnia—Docetaxel—head and neck cancer	0.00072	0.00473	CcSEcCtD
Desloratadine—Dyspnoea—Docetaxel—head and neck cancer	0.000709	0.00466	CcSEcCtD
Desloratadine—Somnolence—Docetaxel—head and neck cancer	0.000707	0.00465	CcSEcCtD
Desloratadine—Vomiting—Fluorouracil—head and neck cancer	0.000701	0.00461	CcSEcCtD
Desloratadine—Dyspepsia—Docetaxel—head and neck cancer	0.0007	0.0046	CcSEcCtD
Desloratadine—CYP1A2—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A1—head and neck cancer	0.000696	0.0241	CbGpPWpGaD
Desloratadine—Rash—Fluorouracil—head and neck cancer	0.000695	0.00457	CcSEcCtD
Desloratadine—Dermatitis—Fluorouracil—head and neck cancer	0.000694	0.00456	CcSEcCtD
Desloratadine—Decreased appetite—Docetaxel—head and neck cancer	0.000692	0.00455	CcSEcCtD
Desloratadine—Headache—Fluorouracil—head and neck cancer	0.000691	0.00454	CcSEcCtD
Desloratadine—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.000687	0.00452	CcSEcCtD
Desloratadine—Fatigue—Docetaxel—head and neck cancer	0.000686	0.00451	CcSEcCtD
Desloratadine—Nausea—Fluorouracil—head and neck cancer	0.000655	0.0043	CcSEcCtD
Desloratadine—Gastrointestinal pain—Docetaxel—head and neck cancer	0.000651	0.00428	CcSEcCtD
Desloratadine—CYP1A2—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A1—head and neck cancer	0.000633	0.0219	CbGpPWpGaD
Desloratadine—Body temperature increased—Docetaxel—head and neck cancer	0.000629	0.00413	CcSEcCtD
Desloratadine—Abdominal pain—Docetaxel—head and neck cancer	0.000629	0.00413	CcSEcCtD
Desloratadine—HRH1—IL-4 Signaling Pathway—STAT6—head and neck cancer	0.000603	0.0209	CbGpPWpGaD
Desloratadine—Hypersensitivity—Docetaxel—head and neck cancer	0.000586	0.00385	CcSEcCtD
Desloratadine—Asthenia—Docetaxel—head and neck cancer	0.000571	0.00375	CcSEcCtD
Desloratadine—Pruritus—Docetaxel—head and neck cancer	0.000563	0.0037	CcSEcCtD
Desloratadine—Diarrhoea—Docetaxel—head and neck cancer	0.000544	0.00358	CcSEcCtD
Desloratadine—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—head and neck cancer	0.000535	0.0185	CbGpPWpGaD
Desloratadine—Dizziness—Docetaxel—head and neck cancer	0.000526	0.00346	CcSEcCtD
Desloratadine—Vomiting—Docetaxel—head and neck cancer	0.000506	0.00333	CcSEcCtD
Desloratadine—Rash—Docetaxel—head and neck cancer	0.000502	0.0033	CcSEcCtD
Desloratadine—Dermatitis—Docetaxel—head and neck cancer	0.000501	0.00329	CcSEcCtD
Desloratadine—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—head and neck cancer	0.0005	0.0173	CbGpPWpGaD
Desloratadine—Headache—Docetaxel—head and neck cancer	0.000498	0.00328	CcSEcCtD
Desloratadine—Nausea—Docetaxel—head and neck cancer	0.000473	0.00311	CcSEcCtD
Desloratadine—CYP1A2—Estrogen Receptor Pathway—CYP1A1—head and neck cancer	0.000472	0.0163	CbGpPWpGaD
Desloratadine—CYP2D6—Fatty Acid Omega Oxidation—CYP1A1—head and neck cancer	0.000472	0.0163	CbGpPWpGaD
Desloratadine—CYP2C19—Xenobiotics—CYP1A1—head and neck cancer	0.000429	0.0149	CbGpPWpGaD
Desloratadine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—head and neck cancer	0.000427	0.0148	CbGpPWpGaD
Desloratadine—CYP2C19—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.000413	0.0143	CbGpPWpGaD
Desloratadine—CYP1A2—Fatty Acid Omega Oxidation—CYP1A1—head and neck cancer	0.0004	0.0138	CbGpPWpGaD
Desloratadine—CYP2D6—Xenobiotics—CYP1A1—head and neck cancer	0.000395	0.0137	CbGpPWpGaD
Desloratadine—CYP2C9—Xenobiotics—CYP1A1—head and neck cancer	0.000391	0.0135	CbGpPWpGaD
Desloratadine—CYP1A2—Estrogen metabolism—GSTM1—head and neck cancer	0.000384	0.0133	CbGpPWpGaD
Desloratadine—CYP2D6—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.00038	0.0131	CbGpPWpGaD
Desloratadine—CYP2C9—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.000376	0.013	CbGpPWpGaD
Desloratadine—CYP1A2—Estrogen metabolism—CYP1A1—head and neck cancer	0.000364	0.0126	CbGpPWpGaD
Desloratadine—CYP1A2—Xenobiotics—CYP1A1—head and neck cancer	0.000334	0.0116	CbGpPWpGaD
Desloratadine—CYP1A2—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.000322	0.0111	CbGpPWpGaD
Desloratadine—CYP2C19—Melatonin metabolism and effects—CYP1A1—head and neck cancer	0.000319	0.011	CbGpPWpGaD
Desloratadine—CYP2D6—Melatonin metabolism and effects—CYP1A1—head and neck cancer	0.000293	0.0101	CbGpPWpGaD
Desloratadine—HRH1—G alpha (q) signalling events—KISS1—head and neck cancer	0.000279	0.00966	CbGpPWpGaD
Desloratadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—KISS1—head and neck cancer	0.00025	0.00864	CbGpPWpGaD
Desloratadine—CYP1A2—Melatonin metabolism and effects—CYP1A1—head and neck cancer	0.000248	0.0086	CbGpPWpGaD
Desloratadine—HRH1—G alpha (q) signalling events—GRP—head and neck cancer	0.00023	0.00796	CbGpPWpGaD
Desloratadine—CYP1A2—Estrogen Receptor Pathway—STAT3—head and neck cancer	0.000219	0.00758	CbGpPWpGaD
Desloratadine—CYP1A2—Phase II conjugation—NAT2—head and neck cancer	0.000218	0.00756	CbGpPWpGaD
Desloratadine—CYP2C19—Arachidonic acid metabolism—GPX1—head and neck cancer	0.000208	0.00721	CbGpPWpGaD
Desloratadine—CYP2C19—Arachidonic acid metabolism—CYP1A1—head and neck cancer	0.000206	0.00714	CbGpPWpGaD
Desloratadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—GRP—head and neck cancer	0.000206	0.00712	CbGpPWpGaD
Desloratadine—CYP2C9—Arachidonic acid metabolism—GPX1—head and neck cancer	0.00019	0.00657	CbGpPWpGaD
Desloratadine—CYP2C9—Arachidonic acid metabolism—CYP1A1—head and neck cancer	0.000188	0.00651	CbGpPWpGaD
Desloratadine—HRH1—Class A/1 (Rhodopsin-like receptors)—KISS1—head and neck cancer	0.000185	0.0064	CbGpPWpGaD
Desloratadine—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000178	0.00617	CbGpPWpGaD
Desloratadine—CYP2C19—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000176	0.00609	CbGpPWpGaD
Desloratadine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1A1—head and neck cancer	0.000172	0.00594	CbGpPWpGaD
Desloratadine—CYP1A2—Aryl Hydrocarbon Receptor—CYP1A1—head and neck cancer	0.000172	0.00594	CbGpPWpGaD
Desloratadine—CYP1A2—Tryptophan metabolism—CYP1A1—head and neck cancer	0.000172	0.00594	CbGpPWpGaD
Desloratadine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000164	0.00567	CbGpPWpGaD
Desloratadine—CYP2C19—Biological oxidations—NAT2—head and neck cancer	0.000164	0.00567	CbGpPWpGaD
Desloratadine—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000163	0.00562	CbGpPWpGaD
Desloratadine—CYP1A2—Arachidonic acid metabolism—GPX1—head and neck cancer	0.000162	0.00562	CbGpPWpGaD
Desloratadine—CYP2D6—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000162	0.0056	CbGpPWpGaD
Desloratadine—CYP2C19—Metapathway biotransformation—NAT2—head and neck cancer	0.000162	0.0056	CbGpPWpGaD
Desloratadine—CYP1A2—Arachidonic acid metabolism—CYP1A1—head and neck cancer	0.000161	0.00556	CbGpPWpGaD
Desloratadine—CYP2C9—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.00016	0.00555	CbGpPWpGaD
Desloratadine—HRH1—Class A/1 (Rhodopsin-like receptors)—GRP—head and neck cancer	0.000152	0.00527	CbGpPWpGaD
Desloratadine—CYP2D6—Biological oxidations—NAT2—head and neck cancer	0.000151	0.00522	CbGpPWpGaD
Desloratadine—CYP2C9—Biological oxidations—NAT2—head and neck cancer	0.000149	0.00517	CbGpPWpGaD
Desloratadine—CYP2D6—Metapathway biotransformation—NAT2—head and neck cancer	0.000149	0.00515	CbGpPWpGaD
Desloratadine—CYP2C9—Metapathway biotransformation—NAT2—head and neck cancer	0.000147	0.0051	CbGpPWpGaD
Desloratadine—CYP2C19—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000144	0.005	CbGpPWpGaD
Desloratadine—HRH1—GPCR ligand binding—KISS1—head and neck cancer	0.000141	0.00487	CbGpPWpGaD
Desloratadine—HRH1—IL-4 Signaling Pathway—STAT3—head and neck cancer	0.000139	0.00482	CbGpPWpGaD
Desloratadine—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000139	0.00481	CbGpPWpGaD
Desloratadine—CYP1A2—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000137	0.00474	CbGpPWpGaD
Desloratadine—ABCB1—Integrated Pancreatic Cancer Pathway—RARB—head and neck cancer	0.000135	0.00466	CbGpPWpGaD
Desloratadine—HRH1—IL-4 Signaling Pathway—MAPK3—head and neck cancer	0.000133	0.0046	CbGpPWpGaD
Desloratadine—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000133	0.0046	CbGpPWpGaD
Desloratadine—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000132	0.00456	CbGpPWpGaD
Desloratadine—CYP1A2—Biological oxidations—NAT2—head and neck cancer	0.000128	0.00442	CbGpPWpGaD
Desloratadine—HRH1—IL-4 Signaling Pathway—MAPK1—head and neck cancer	0.000127	0.00438	CbGpPWpGaD
Desloratadine—CYP1A2—Metapathway biotransformation—NAT2—head and neck cancer	0.000126	0.00436	CbGpPWpGaD
Desloratadine—CYP2C19—Arachidonic acid metabolism—PTGS2—head and neck cancer	0.000123	0.00424	CbGpPWpGaD
Desloratadine—ABCB1—Integrated Pancreatic Cancer Pathway—RAD51—head and neck cancer	0.000122	0.00424	CbGpPWpGaD
Desloratadine—HRH1—GPCR ligand binding—GRP—head and neck cancer	0.000116	0.00401	CbGpPWpGaD
Desloratadine—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000113	0.0039	CbGpPWpGaD
Desloratadine—CYP2C9—Arachidonic acid metabolism—PTGS2—head and neck cancer	0.000112	0.00387	CbGpPWpGaD
Desloratadine—HRH1—IL-4 Signaling Pathway—PIK3CA—head and neck cancer	0.00011	0.0038	CbGpPWpGaD
Desloratadine—CYP1A2—Phase II conjugation—GSTM1—head and neck cancer	0.000108	0.00373	CbGpPWpGaD
Desloratadine—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—head and neck cancer	0.000102	0.00354	CbGpPWpGaD
Desloratadine—ABCB1—Allograft Rejection—CASP8—head and neck cancer	0.000102	0.00352	CbGpPWpGaD
Desloratadine—CYP1A2—Arachidonic acid metabolism—PTGS2—head and neck cancer	9.56e-05	0.00331	CbGpPWpGaD
Desloratadine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—head and neck cancer	9.47e-05	0.00328	CbGpPWpGaD
Desloratadine—HRH1—IL-4 Signaling Pathway—AKT1—head and neck cancer	8.97e-05	0.00311	CbGpPWpGaD
Desloratadine—CYP2C19—Biological oxidations—GSTM1—head and neck cancer	8.1e-05	0.0028	CbGpPWpGaD
Desloratadine—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—head and neck cancer	8.05e-05	0.00278	CbGpPWpGaD
Desloratadine—CYP2C19—Metapathway biotransformation—GSTM1—head and neck cancer	7.98e-05	0.00276	CbGpPWpGaD
Desloratadine—HRH1—GPCR downstream signaling—KISS1—head and neck cancer	7.96e-05	0.00275	CbGpPWpGaD
Desloratadine—ABCB1—Allograft Rejection—IL2—head and neck cancer	7.69e-05	0.00266	CbGpPWpGaD
Desloratadine—CYP2C19—Biological oxidations—CYP1A1—head and neck cancer	7.67e-05	0.00266	CbGpPWpGaD
Desloratadine—CYP2C19—Metapathway biotransformation—CYP1A1—head and neck cancer	7.57e-05	0.00262	CbGpPWpGaD
Desloratadine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—head and neck cancer	7.55e-05	0.00261	CbGpPWpGaD
Desloratadine—CYP2D6—Biological oxidations—GSTM1—head and neck cancer	7.45e-05	0.00258	CbGpPWpGaD
Desloratadine—ABCB1—Transmembrane transport of small molecules—ATP7B—head and neck cancer	7.39e-05	0.00256	CbGpPWpGaD
Desloratadine—CYP2C9—Biological oxidations—GSTM1—head and neck cancer	7.38e-05	0.00255	CbGpPWpGaD
Desloratadine—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—head and neck cancer	7.35e-05	0.00254	CbGpPWpGaD
Desloratadine—CYP2D6—Metapathway biotransformation—GSTM1—head and neck cancer	7.34e-05	0.00254	CbGpPWpGaD
Desloratadine—CYP2C9—Metapathway biotransformation—GSTM1—head and neck cancer	7.28e-05	0.00252	CbGpPWpGaD
Desloratadine—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—head and neck cancer	7.24e-05	0.00251	CbGpPWpGaD
Desloratadine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—head and neck cancer	7.24e-05	0.00251	CbGpPWpGaD
Desloratadine—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—head and neck cancer	7.24e-05	0.00251	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—KISS1—head and neck cancer	7.22e-05	0.0025	CbGpPWpGaD
Desloratadine—CYP2D6—Biological oxidations—CYP1A1—head and neck cancer	7.06e-05	0.00244	CbGpPWpGaD
Desloratadine—CYP2C9—Biological oxidations—CYP1A1—head and neck cancer	7e-05	0.00242	CbGpPWpGaD
Desloratadine—CYP2D6—Metapathway biotransformation—CYP1A1—head and neck cancer	6.96e-05	0.00241	CbGpPWpGaD
Desloratadine—CYP2C9—Metapathway biotransformation—CYP1A1—head and neck cancer	6.9e-05	0.00239	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—UROD—head and neck cancer	6.75e-05	0.00234	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—UROD—head and neck cancer	6.59e-05	0.00228	CbGpPWpGaD
Desloratadine—HRH1—GPCR downstream signaling—GRP—head and neck cancer	6.55e-05	0.00227	CbGpPWpGaD
Desloratadine—ABCB1—Allograft Rejection—VEGFA—head and neck cancer	6.54e-05	0.00226	CbGpPWpGaD
Desloratadine—CYP1A2—Biological oxidations—GSTM1—head and neck cancer	6.31e-05	0.00218	CbGpPWpGaD
Desloratadine—CYP1A2—Metapathway biotransformation—GSTM1—head and neck cancer	6.22e-05	0.00215	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—UROD—head and neck cancer	6.21e-05	0.00215	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—UROD—head and neck cancer	6.16e-05	0.00213	CbGpPWpGaD
Desloratadine—CYP1A2—Biological oxidations—CYP1A1—head and neck cancer	5.98e-05	0.00207	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—GRP—head and neck cancer	5.95e-05	0.00206	CbGpPWpGaD
Desloratadine—CYP1A2—Metapathway biotransformation—CYP1A1—head and neck cancer	5.9e-05	0.00204	CbGpPWpGaD
Desloratadine—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—head and neck cancer	5.81e-05	0.00201	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—UROD—head and neck cancer	5.26e-05	0.00182	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	5.24e-05	0.00181	CbGpPWpGaD
Desloratadine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—head and neck cancer	5.03e-05	0.00174	CbGpPWpGaD
Desloratadine—ABCB1—HIF-1-alpha transcription factor network—AKT1—head and neck cancer	4.82e-05	0.00167	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	4.78e-05	0.00165	CbGpPWpGaD
Desloratadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—head and neck cancer	4.4e-05	0.00152	CbGpPWpGaD
Desloratadine—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—head and neck cancer	4.31e-05	0.00149	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—KISS1—head and neck cancer	4.27e-05	0.00148	CbGpPWpGaD
Desloratadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—head and neck cancer	4.19e-05	0.00145	CbGpPWpGaD
Desloratadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—head and neck cancer	4.19e-05	0.00145	CbGpPWpGaD
Desloratadine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—head and neck cancer	4.1e-05	0.00142	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	4.08e-05	0.00141	CbGpPWpGaD
Desloratadine—HRH1—G alpha (q) signalling events—PIK3CA—head and neck cancer	4.07e-05	0.00141	CbGpPWpGaD
Desloratadine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—head and neck cancer	3.7e-05	0.00128	CbGpPWpGaD
Desloratadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—head and neck cancer	3.64e-05	0.00126	CbGpPWpGaD
Desloratadine—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—head and neck cancer	3.57e-05	0.00124	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—GRP—head and neck cancer	3.51e-05	0.00122	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—STAT6—head and neck cancer	3.41e-05	0.00118	CbGpPWpGaD
Desloratadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—head and neck cancer	3.36e-05	0.00116	CbGpPWpGaD
Desloratadine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—head and neck cancer	3.23e-05	0.00112	CbGpPWpGaD
Desloratadine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—head and neck cancer	3.05e-05	0.00106	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—YAP1—head and neck cancer	3.02e-05	0.00105	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	2.98e-05	0.00103	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	2.95e-05	0.00102	CbGpPWpGaD
Desloratadine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—head and neck cancer	2.9e-05	0.00101	CbGpPWpGaD
Desloratadine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—head and neck cancer	2.9e-05	0.00101	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—NAT2—head and neck cancer	2.8e-05	0.00097	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—NAT2—head and neck cancer	2.74e-05	0.000947	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	2.71e-05	0.000939	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	2.69e-05	0.00093	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—NAT2—head and neck cancer	2.58e-05	0.000892	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—NAT2—head and neck cancer	2.56e-05	0.000885	CbGpPWpGaD
Desloratadine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—head and neck cancer	2.52e-05	0.000872	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—DPYD—head and neck cancer	2.46e-05	0.000851	CbGpPWpGaD
Desloratadine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—head and neck cancer	2.44e-05	0.000844	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—DPYD—head and neck cancer	2.4e-05	0.00083	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—YAP1—head and neck cancer	2.33e-05	0.000807	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	2.32e-05	0.000803	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	2.3e-05	0.000795	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—YAP1—head and neck cancer	2.28e-05	0.000788	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—DPYD—head and neck cancer	2.26e-05	0.000782	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—DPYD—head and neck cancer	2.24e-05	0.000776	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—NAT2—head and neck cancer	2.18e-05	0.000756	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—YAP1—head and neck cancer	2.15e-05	0.000742	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—YAP1—head and neck cancer	2.13e-05	0.000736	CbGpPWpGaD
Desloratadine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—head and neck cancer	2.06e-05	0.000713	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—DPYD—head and neck cancer	1.92e-05	0.000663	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—YAP1—head and neck cancer	1.82e-05	0.000629	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	1.75e-05	0.000607	CbGpPWpGaD
Desloratadine—HRH1—GPCR downstream signaling—IL2—head and neck cancer	1.75e-05	0.000604	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	1.6e-05	0.000553	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—IL2—head and neck cancer	1.59e-05	0.000549	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	1.53e-05	0.000529	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—TYMS—head and neck cancer	1.4e-05	0.000485	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	1.39e-05	0.000482	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—GSTM1—head and neck cancer	1.38e-05	0.000479	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—TYMS—head and neck cancer	1.37e-05	0.000473	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	1.37e-05	0.000473	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—NOTCH1—head and neck cancer	1.36e-05	0.000471	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—GSTM1—head and neck cancer	1.35e-05	0.000468	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—GPX1—head and neck cancer	1.33e-05	0.000459	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—CYP1A1—head and neck cancer	1.31e-05	0.000454	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—GPX1—head and neck cancer	1.29e-05	0.000448	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—TYMS—head and neck cancer	1.29e-05	0.000446	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—CYP1A1—head and neck cancer	1.28e-05	0.000443	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—TYMS—head and neck cancer	1.28e-05	0.000442	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—MAPK3—head and neck cancer	1.27e-05	0.000441	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—GSTM1—head and neck cancer	1.27e-05	0.000441	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—GSTM1—head and neck cancer	1.26e-05	0.000437	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—GPX1—head and neck cancer	1.22e-05	0.000422	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—MAPK1—head and neck cancer	1.21e-05	0.00042	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—EGFR—head and neck cancer	1.21e-05	0.00042	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—GPX1—head and neck cancer	1.21e-05	0.000418	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—CYP1A1—head and neck cancer	1.21e-05	0.000418	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—CYP1A1—head and neck cancer	1.2e-05	0.000414	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	1.19e-05	0.000412	CbGpPWpGaD
Desloratadine—HRH1—GPCR downstream signaling—PIK3CA—head and neck cancer	1.16e-05	0.000401	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—TYMS—head and neck cancer	1.09e-05	0.000378	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—GSTM1—head and neck cancer	1.08e-05	0.000373	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	1.08e-05	0.000373	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—PIK3CA—head and neck cancer	1.05e-05	0.000364	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—GPX1—head and neck cancer	1.03e-05	0.000358	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—CYP1A1—head and neck cancer	1.02e-05	0.000354	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	9.83e-06	0.00034	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—HRAS—head and neck cancer	9.74e-06	0.000337	CbGpPWpGaD
Desloratadine—HRH1—GPCR downstream signaling—AKT1—head and neck cancer	9.47e-06	0.000328	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—IL2—head and neck cancer	9.36e-06	0.000324	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—CCND1—head and neck cancer	9.13e-06	0.000316	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—PTEN—head and neck cancer	8.81e-06	0.000305	CbGpPWpGaD
Desloratadine—HRH1—Signaling by GPCR—AKT1—head and neck cancer	8.6e-06	0.000298	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	8.4e-06	0.000291	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—VEGFA—head and neck cancer	7.96e-06	0.000275	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—STAT3—head and neck cancer	7.88e-06	0.000273	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—PTGS2—head and neck cancer	7.81e-06	0.00027	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—PTGS2—head and neck cancer	7.62e-06	0.000264	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—MAPK3—head and neck cancer	7.53e-06	0.000261	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—PTGS2—head and neck cancer	7.18e-06	0.000248	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—MAPK1—head and neck cancer	7.16e-06	0.000248	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—EGFR—head and neck cancer	7.16e-06	0.000248	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—PTGS2—head and neck cancer	7.12e-06	0.000246	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—PTEN—head and neck cancer	6.81e-06	0.000236	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—PTEN—head and neck cancer	6.64e-06	0.00023	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—PTEN—head and neck cancer	6.26e-06	0.000217	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—PIK3CA—head and neck cancer	6.22e-06	0.000215	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—PTEN—head and neck cancer	6.21e-06	0.000215	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—PTGS2—head and neck cancer	6.08e-06	0.00021	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—TP53—head and neck cancer	6.01e-06	0.000208	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—HRAS—head and neck cancer	5.75e-06	0.000199	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—PTEN—head and neck cancer	5.3e-06	0.000184	CbGpPWpGaD
Desloratadine—HRH1—Signaling Pathways—AKT1—head and neck cancer	5.08e-06	0.000176	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—PIK3CA—head and neck cancer	4.8e-06	0.000166	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—PIK3CA—head and neck cancer	4.69e-06	0.000162	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—PIK3CA—head and neck cancer	4.42e-06	0.000153	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—PIK3CA—head and neck cancer	4.38e-06	0.000152	CbGpPWpGaD
Desloratadine—CYP2C19—Metabolism—AKT1—head and neck cancer	3.92e-06	0.000136	CbGpPWpGaD
Desloratadine—ABCB1—Metabolism—AKT1—head and neck cancer	3.83e-06	0.000133	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—PIK3CA—head and neck cancer	3.74e-06	0.000129	CbGpPWpGaD
Desloratadine—CYP2D6—Metabolism—AKT1—head and neck cancer	3.61e-06	0.000125	CbGpPWpGaD
Desloratadine—CYP2C9—Metabolism—AKT1—head and neck cancer	3.58e-06	0.000124	CbGpPWpGaD
Desloratadine—CYP1A2—Metabolism—AKT1—head and neck cancer	3.06e-06	0.000106	CbGpPWpGaD
